LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
UJET Secures $76 Million to Elevate AI in Contact CentresBy News Team24/09/2024 UJET has marked a significant milestone by securing $76 million in Series D funding, aimed at advancing generative AI capabilities within contact centres.This substantial investment will…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
